Avalo Therapeutics Inc

AVTX USD0.001
Create an alert
Sell$16.18
Buy$22.30
$0.06 (0.37%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 September 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Option/Award related
10,185$17.62$179,456.6439,900
28 August 2026
Mittie DoyleOther Level A
Sell
Option/Award related
679$20.00$13,580.0051,776
18 August 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Option/Award related
31,031$20.05$622,323.6039,900
17 August 2026
Mittie DoyleOther Level A
Sell
Option/Award related
1,000$20.00$20,000.0051,776
17 August 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Option/Award related
37,945$19.85$753,333.4743,649
17 August 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Regular sell transaction (market)
3,749$19.94$74,762.1839,900
11 August 2026
Jennifer RileyChief Level Officer
Sell
Regular sell transaction (market)
2,655$19.59$52,012.2537,041
10 August 2026
Mittie DoyleOther Level A
Sell
Option/Award related
679$20.00$13,580.0051,776
27 July 2026
Mittie DoyleOther Level A
Sell
Option/Award related
1,000$20.00$20,000.0051,776
30 June 2026
Mittie DoyleOther Level A
Sell
Option/Award related
4,654$20.00$93,080.0051,776

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
6 May 2026
Mittie DoyleOther Level A
Sell
Option/Award related
44,944$21.20$952,668.9832,695
17 August 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Option/Award related
37,945$19.85$753,333.4743,649
6 May 2026
Paul VarkiChief Legal/Compliance Officer
Sell
Option/Award related
37,375$18.91$706,836.0041,322
18 August 2026
Christopher Ryan (Chris) SullivanCFO
Sell
Option/Award related
31,031$20.05$622,323.6039,900
6 May 2026
Mittie DoyleOther Level A
Sell
Option/Award related
27,538$18.03$496,405.5082,639

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.